Hyperlipidemia
Hyperlipidemia refers to high blood lipid levels, which is a systemic disease caused by abnormal fat metabolism or operation, making plasma lipids higher than normal. It refers to high cholesterol or triglycerides in the blood, or low high-density lipoprotein cholesterol. Modern medicine calls it dyslipidemia. Hyperlipidemia can be divided into primary and secondary types. The former is related to the environment and family inheritance. The latter is caused by diabetes, hypothyroidism, obesity, pancreatitis, etc. It is particularly common in middle-aged and elderly people. According to statistics, the number of people with hyperlipidemia has reached 200 million. In addition, since there are no obvious symptoms in the early stage of hyperlipidemia, it is easy to be ignored by patients. It all happens unconsciously and can only be discovered during health examinations. Therefore, it is also called: the silent killer.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Obese people -
Related symptoms:
Vascular sclerosis yellow nodules high blood pressure unstable angina diabetes -
Concurrent disease:
Related Drugs
Lotus leaf fat-regulating tea
Manufacturer:
Beijing Kangbide Pharmaceutical Co., Ltd.
Atorvastatin calcium
Indication: This drug can treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides. Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product if the effects of diet therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies or alone (when no other treatments are available) to lower total cholesterol and low-density lipoprotein cholesterol. It is mainly suitable for the treatment of hypercholesterolemia and mixed hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Manufacturer:
CSPC OUYI Pharmaceutical Co., Ltd.
Atorvastatin calcium
Indication: This drug can treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides. Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product if the effects of diet therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies or alone (when no other treatments are available) to lower total cholesterol and low-density lipoprotein cholesterol. It is mainly suitable for the treatment of hypercholesterolemia and mixed hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Atorvastatin calcium
Indication: This drug can treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides. Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product if the effects of diet therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies or alone (when no other treatments are available) to lower total cholesterol and low-density lipoprotein cholesterol. It is mainly suitable for the treatment of hypercholesterolemia and mixed hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Atorvastatin calcium
Indication: This drug can treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides. Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product if the effects of diet therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies or alone (when no other treatments are available) to lower total cholesterol and low-density lipoprotein cholesterol. It is mainly suitable for the treatment of hypercholesterolemia and mixed hyperlipidemia; prevention and treatment of coronary heart disease and cerebral stroke.
Tingli hypolipidemic tablets
Manufacturer:
Fujian MING WAH MEDICAL Industral Co., Ltd.
Furazanolone Tablets
Indication: 1. Protein anabolic hormone. Suitable for patients with hyperlipidemia (hypercholesterolemia, hypertriglyceridemia) and atherosclerosis; 2. Can be used for wasting diseases such as trauma, chronic infection, malnutrition, etc.
Furazanolone Tablets
Indication: 1. Protein anabolic hormone. Suitable for patients with hyperlipidemia (hypercholesterolemia, hypertriglyceridemia) and atherosclerosis; 2. Can be used for wasting diseases such as trauma, chronic infection, malnutrition, etc.
Manufacturer:
Hainan Pharmaceutical Factory Co., Ltd. Pharmaceutical Factory No.1
Furazanolone Tablets
Indication: 1. Protein anabolic hormone. Suitable for patients with hyperlipidemia (hypercholesterolemia, hypertriglyceridemia) and atherosclerosis; 2. Can be used for wasting diseases such as trauma, chronic infection, malnutrition, etc.
Manufacturer:
BESTWAY Pharmaceutical Co., Ltd.
Furazanolone Tablets
Indication: 1. Protein anabolic hormone. Suitable for patients with hyperlipidemia (hypercholesterolemia, hypertriglyceridemia) and atherosclerosis; 2. Can be used for wasting diseases such as trauma, chronic infection, malnutrition, etc.
Manufacturer:
China Resources Double-Crane Pharmaceutical Co., Ltd.
Related Ingredients
-
Atorvastatin calcium list
134523-03-8 -
Chrysophanic acid list
481-74-3 -
Furazabol list
1239-29-8